-+ 0.00%
-+ 0.00%
-+ 0.00%

Acadia R&D chief Elizabeth Thompson to retire, company launches successor search

PUBT·04/30/2026 20:19:33
Listen to the news
Acadia R&D chief Elizabeth Thompson to retire, company launches successor search
  • Acadia Pharmaceuticals Head of Research and Development Elizabeth H.Z. Thompson plans to retire at year-end for personal reasons.
  • Thompson will stay in role until successor is appointed.
  • Company started search for new Head of Research and Development.
  • Acadia plans to retain Thompson as consultant through at least end of 2026 to support continuity through Phase 2 remlifanserin readout in Alzheimer’s disease psychosis.
  • Consulting arrangement is also intended to support early Phase 3 execution for remlifanserin.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604301605BIZWIRE_USPR_____20260430_BW350268) on April 30, 2026, and is solely responsible for the information contained therein.